We also investigated whether MRTX849-induced ABCC1 up-regulation affects the sensitivity of gemcitabine, a commonly used chemotherapy drug in the treatment of advanced NSCLC and pancreatic cancer. The gene discussed is ABCC1; the disease is familial pancreatic carcinoma.